Altered CD45 expression and disease

Trends in Immunology

Volumn 27, Issue 3, 2006, Pages 146-153

  Tchilian, Elma Z ^a   Beverley, Peter C L ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; IMMUNOMODULATING AGENT; LYMPHOCYTE ANTIGEN RECEPTOR;

ALLELE; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; DNA MODIFICATION; DNA POLYMORPHISM; EXON; HEMATOPOIETIC CELL; HUMAN; IMMUNOMODULATION; INFECTION; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 33644557158     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2006.01.001     Document Type: Review

References (71)

1. M.L. Hermiston CD45: A critical regulator of signaling thresholds in immune cells Annu. Rev. Immunol. 21 2003 107 137
2. J.M. Penninger CD45: new jobs for an old acquaintance Nat. Immunol. 2 2001 389 396
3. K.F. Byth CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation J. Exp. Med. 183 1996 1707 1718
4. C. Kung Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease Nat. Med. 6 2000 343 345
5. E.Z. Tchilian A deletion in the gene encoding the CD45 antigen in a patient with SCID J. Immunol. 166 2001 1308 1313
6. E. Diaz del Pozo Genomic structure and sequence of the leukocyte common antigen (CD45) from the pufferfish Fugu rubripes and comparison with its mammalian homologue Immunogenetics 51 2000 838 846
7. T. Uinuk-Ool Organization, alternative splicing, polymorphism, and phylogenetic position of lamprey CD45 gene Immunogenetics 57 2005 607 617
8. M.F. Seldin Allelic variants of Ly-5 in inbred and natural populations of mice Immunogenetics 26 1987 74 78
9. W.C. Raschke Genetic basis of antigenic differences between three alleles of Ly5 (CD45) in mice Immunogenetics 41 1995 144 147
10. A. Symons, and A.N. Barclay Molecular basis of antigenic differences between the RT7 alleles of rat CD45 Immunogenetics 51 2000 747 750
11. K.T. Ballingall The CD45 locus in cattle: allelic polymorphism and evidence for exceptional positive natural selection Immunogenetics 52 2001 276 283
12. L.C. Filip, and N.I. Mundy Rapid evolution by positive Darwinian selection in the extracellular domain of the abundant lymphocyte protein CD45 in primates Mol. Biol. Evol. 21 2004 1504 1511
13. M. Okumura Comparision of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains J. Immunol. 157 1996 1569 1575
14. H. Thude A point mutation in the human CD45 gene associated with defective splicing of exon A Eur. J. Immunol. 25 1995 2101 2106
15. T. Stanton A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression Proc. Natl. Acad. Sci. U. S. A. 100 2003 5997 6002
16. M. Gomez-Lira CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers J. Neuroimmunol. 140 2003 216 221
17. M. Jacobsen A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule Immunogenetics 54 2002 158 163
18. K.W. Lynch, and A. Weiss A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer J. Biol. Chem. 276 2001 24341 24347
19. M. Jacobsen A point mutation in PTPRC is associated with the development of multiple sclerosis Nat. Genet. 26 2000 495 499
20. C. Ballerini Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population Neurosci. Lett. 328 2002 325 327
21. T. Vyshkina CD45 (PTPRC) as a candidate gene in multiple sclerosis Mult. Scler. 10 2004 614 617
22. L.F. Barcellos PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients Nat. Genet. 29 2001 23 24
23. I. Vorechovsky Does 77C→G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat. Genet. 29 2001 22 23
24. R.S. Nicholas The role of the PTPRC (CD45) mutation in the development of multiple sclerosis in the North West region of the United Kingdom J. Neurol. Neurosurg. Psychiatry 74 2003 944 945
25. E. Cocco PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients J. Neurol. 251 2004 1085 1088
26. E.Z. Tchilian A point mutation in CD45 may be associated with HIV-1 infection AIDS 15 2001 1892 1894
27. S. Boxall Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis Pediatr. Res. 55 2004 478 484
28. R. Schwinzer Enhanced frequency of a PTPRC (CD45) exon A mutation (77C→G) in systemic sclerosis Genes Immun. 4 2003 168 169
29. A. Vogel 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link Genes Immun. 4 2003 79 81
30. J.P. Wood CD45 exon 4 point mutation does not confer susceptibility to type 1 diabetes mellitus or Graves' disease Eur. J. Immunogenet. 29 2002 73 74
31. H. Thude A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population Eur. J. Immunogenet. 31 2004 245 247
32. B. Tackenberg CD45 isoform expression in autoimmune myasthenia gravis Autoimmunity 36 2003 117 121
33. W. Bujan Abnormal T-cell phenotype in familial erythrophagocytic lymphohistiocytosis Lancet 342 1993 1296
34. R. Wagner A prospective study of CD45 isoform expression in haemophagocytic lymphohistiocytosis; an abnormal inherited immunophenotype in one family Clin. Exp. Immunol. 99 1995 216 220
35. H.T. Do Functional significance of the 77C → G polymorphism in the human CD45 gene: enhanced T-cell reactivity by variantly expressed CD45RA isoforms Transplant. Proc. 37 2005 51 52
36. T. Stanton CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans Immunogenetics 56 2004 107 110
37. A. Tong Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons J. Biol. Chem. 280 2005 38297 38304
38. S. Boxall Disease associations and altered immune function in CD45 138G variant carriers Hum. Mol. Genet. 13 2004 2377 2384
39. G.B. ten Dam Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors J. Immunol. 164 2000 5287 5295
40. C. Rothrock A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45 Mol. Cell 12 2003 1317 1324
41. K.W. Lynch Consequences of regulated pre-mRNA splicing in the immune system Nat. Rev. Immunol. 4 2004 931 940
42. J.F. Subra The balance between CD45RChigh and CD45RClow CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled J. Immunol. 166 2001 2944 2952
43. E. Xystrakis Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat J. Immunol. 173 2004 3140 3147
44. R. Majeti An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity Cell 103 2000 1059 1070
45. T. Mustelin Protein tyrosine phosphatases and the immune response Nat. Rev. Immunol. 5 2005 43 57
46. K. Choudhuri T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand Nature 436 2005 578 582
47. N.D. Huntington A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells J. Exp. Med. 201 2005 1421 1433
48. S.A. Berger Leukocyte common antigen (CD45) is required for immunoglobulin E-mediated degranulation of mast cells J. Exp. Med. 180 1994 471 476
49. H. Gao Effects of the protein tyrosine phosphatase CD45 on Fc gamma RIIa signaling and neutrophil function Exp. Hematol. 28 2000 1062 1070
50. E.F. Petricoin 3rd Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling Nature 390 1997 629 632
51. J. Irie-Sasaki CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling Nature 409 2001 349 354
52. S. Gregori An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells J. Exp. Med. 201 2005 1293 1305
53. N.L. Perillo Apoptosis of T cells mediated by galectin-1 Nature 378 1995 736 739
54. M. Fortin Apoptosis mediated through CD45 is independent of its phosphatase activity and association with leukocyte phosphatase-associated phosphoprotein J. Immunol. 168 2002 6084 6089
55. A.M. Steff A cell death pathway induced by antibody-mediated cross-linking of CD45 on lymphocytes Crit. Rev. Immunol. 23 2003 421 440
56. C. Irles CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling Nat. Immunol. 4 2003 189 197
57. Z. Xu, and A. Weiss Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms Nat. Immunol. 3 2002 764 771
58. H.J. Nam Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45 J. Exp. Med. 201 2005 441 452
59. S. Dornan Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction J. Biol. Chem. 277 2002 1912 1918
60. M. Zhang CD45 signals outside of lipid rafts to promote ERK activation, synaptic raft clustering, and IL-2 production J. Immunol. 174 2005 1479 1490
61. S. Ogilvy Either of the CD45RB and CD45RO isoforms are effective in restoring T cell, but not B cell, development and function in CD45-null mice J. Immunol. 171 2003 1792 1800
62. E.Z. Tchilian Altered CD45 isoform expression affects lymphocyte function in CD45 Tg mice Int. Immunol. 16 2004 1323 1332
63. gld/gld syndrome Cell. Immunol. 212 2001 24 34
64. T. Takeuchi Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE) Clin. Exp. Immunol. 109 1997 20 26
65. J.D. Rioux, and A.K. Abbas Paths to understanding the genetic basis of autoimmune disease Nature 435 2005 584 589
66. D.A. Hafler, and P.L. De Jager Applying a new generation of genetic maps to understand human inflammatory disease Nat. Rev. Immunol. 5 2005 83 91
67. E.Z. Tchilian A CD45 polymorphism associated with abnormal splicing is absent in African populations Immunogenetics 53 2002 980 983
68. B. Miterski PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients BMC Med. Genet. 3 2002 3
69. F. Esteghamat C77G mutation in protein tyrosine phosphatase CD45 gene and autoimmune hepatitis Hepatol. Res. 32 2005 154 157
70. A.H. Sabouri A C77G point mutation in CD45 exon 4, which is associated with the development of multiple sclerosis and increased susceptibility to HIV-1 infection, is undetectable in Japanese population Eur. J. Neurol. 10 2003 737 739
71. J. Gil Prevalence of C77G polymorphism in exon 4 of the CD45 gene in the Spanish population Med. Clin. (Barc.) 125 2005 10 11